Shanghai Sanyou Medical Co., Ltd. (688085.SS)
CNY 19.25
(0.1%)
CNY 19.25
(0.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 212.1 Million CNY | -23.8% |
| 2022 | 278.34 Million CNY | 6.69% |
| 2021 | 260.89 Million CNY | 91.49% |
| 2020 | 136.24 Million CNY | 19.87% |
| 2019 | 113.66 Million CNY | 135.16% |
| 2018 | 48.33 Million CNY | 3.34% |
| 2017 | 46.77 Million CNY | 138.84% |
| 2016 | 19.58 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 243.22 Million CNY | -8.71% |
| 2024 Q1 | 266.42 Million CNY | 25.61% |
| 2024 Q3 | 239.98 Million CNY | -1.33% |
| 2023 Q1 | 278.44 Million CNY | 0.04% |
| 2023 FY | 212.1 Million CNY | -23.8% |
| 2023 Q4 | 212.1 Million CNY | 14.94% |
| 2023 Q3 | 184.54 Million CNY | -25.09% |
| 2023 Q2 | 246.33 Million CNY | -11.53% |
| 2022 Q4 | 278.34 Million CNY | -4.91% |
| 2022 Q3 | 292.7 Million CNY | 5.18% |
| 2022 Q2 | 278.27 Million CNY | 15.19% |
| 2022 Q1 | 241.58 Million CNY | -7.4% |
| 2022 FY | 278.34 Million CNY | 6.69% |
| 2021 Q4 | 260.89 Million CNY | 17.98% |
| 2021 Q2 | 169.16 Million CNY | 17.45% |
| 2021 FY | 260.89 Million CNY | 91.49% |
| 2021 Q3 | 221.14 Million CNY | 30.73% |
| 2021 Q1 | 144.03 Million CNY | 5.71% |
| 2020 Q3 | 101.74 Million CNY | 12.68% |
| 2020 Q1 | 101.04 Million CNY | -11.1% |
| 2020 FY | 136.24 Million CNY | 19.87% |
| 2020 Q4 | 136.24 Million CNY | 33.91% |
| 2020 Q2 | 90.3 Million CNY | -10.64% |
| 2019 Q4 | 113.66 Million CNY | 36.26% |
| 2019 FY | 113.66 Million CNY | 135.16% |
| 2019 Q2 | 86.81 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 83.41 Million CNY | -3.92% |
| 2018 FY | 48.33 Million CNY | 3.34% |
| 2018 Q4 | 48.33 Million CNY | 0.0% |
| 2017 FY | 46.77 Million CNY | 138.84% |
| 2016 FY | 19.58 Million CNY | 0.0% |